| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/070674370104600307 |
| P8608 | Fatcat ID | release_j5oruzko5zdf3cmkfunad7oy3y |
| P698 | PubMed publication ID | 11320681 |
| P2093 | author name string | M D Brownell | |
| M S Yogendran | |||
| P2860 | cites work | Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy | Q36463857 |
| Using administrative data for longitudinal research: comparisons with primary data collection. | Q36482288 | ||
| A method of comparison for standardized rates of low-incidence events | Q38458153 | ||
| Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity | Q39279878 | ||
| Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample | Q39381494 | ||
| NIMH Collaborative Multisite Multimodal Treatment Study of Children with ADHD: I. Background and Rationale | Q40476916 | ||
| The use of methylphenidate in Michigan | Q40983042 | ||
| Attention deficit disorder: a review of the past 10 years | Q41074795 | ||
| Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle | Q41214134 | ||
| Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial | Q42547729 | ||
| The population's use of pharmaceuticals | Q42605798 | ||
| Psychiatric disorders in primary care. Results of a follow-up study | Q43831266 | ||
| More Frequent Diagnosis of Attention Deficit–Hyperactivity Disorder | Q44582922 | ||
| Correlates, associated impairments and patterns of service utilization of children with attention deficit disorder: findings from the Ontario Child Health Study | Q48926143 | ||
| The use of psychotropic medication in preschoolers: indications, safety, and efficacy | Q50301682 | ||
| Child and adolescent psychopharmacology. Important developmental issues. | Q50848459 | ||
| Prevalence variations in psychotropic treatment of children. | Q50867623 | ||
| Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. | Q51980947 | ||
| Alcohol abuse, other drug abuse, and mental disorders in medical practice. Prevalence, costs, recognition, and treatment. | Q52079071 | ||
| Recognition of mental distress and diagnosis of mental disorder in primary care. | Q52083209 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | attention deficit hyperactivity disorder | Q181923 |
| attention | Q6501338 | ||
| P304 | page(s) | 264-272 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Canadian Journal of Psychiatry | Q5030253 |
| P1476 | title | Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates | |
| P478 | volume | 46 |
| Q46919631 | A comparison of North American versus non-North American ADHD study populations |
| Q42635854 | A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. |
| Q27025307 | A review of geographic variation and Geographic Information Systems (GIS) applications in prescription drug use research |
| Q36980430 | Assessing the diagnostic accuracy of the identification of hyperkinetic disorders following the introduction of government guidelines in England |
| Q60920918 | Association of Childhood Social-Emotional Functioning Profiles at School Entry With Early-Onset Mental Health Conditions |
| Q57400259 | Attention-deficit hyperactivity disorder |
| Q24812141 | Birth defects, season of conception, and sex of children born to pesticide applicators living in the Red River Valley of Minnesota, USA |
| Q44510122 | Changing Epidemiology of Methylphenidate Prescriptions in the Community: A Multifactorial Model |
| Q35091073 | Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada |
| Q60584598 | Connaissances et croyances des intervenants des milieux scolaires, de la santé et des services sociaux à l’égard du trouble déficitaire de l’attention/hyperactivité |
| Q36402477 | Correlates of methylphenidate use in Canadian children: a cross-sectional study |
| Q35676640 | Economic implications of attention-deficit hyperactivity disorder for healthcare systems |
| Q46438027 | Individual change in methylphenidate use in a national sample of children aged 2 to 11 years |
| Q42032863 | Life in the last lane |
| Q36371701 | Lifetime Prevalence of Attention-Deficit Hyperactivity Disorder in Young Adults: Examining Variations in the Socioeconomic Gradient |
| Q38791913 | Long-term trends in invasive pneumococcal disease in Manitoba, Canada |
| Q37252623 | Outcomes-based health human resource planning for maternal, child and youth health care in Canada: A new horizon for the 21st century. |
| Q39641799 | Prescription medications in Manitoba children: are there regional differences? |
| Q35812424 | Prevalence of methylphenidate use among Canadian children following parental divorce |
| Q36406035 | Temporal Trends in the Prevalence and Incidence of Diagnosed ADHD in Children and Young Adults between 1999 and 2012 in Canada: A Data Linkage Study |
| Q39779990 | The incidence of methylphenidate use by Canadian children: what is the impact of socioeconomic status and urban or rural residence? |
| Q51116234 | Trends in psychostimulant and antidepressant use by children in 2 Canadian provinces. |
| Q36806482 | Who cares for patients with attention-deficit/hyperactivity disorder (ADHD)? Insights from Nordbaden (Germany) on administrative prevalence and physician involvement in health care provision |
Search more.